Hangzhou Huayuu Biopharma Co., Ltd. (HUAYUU)www.huayuubio.com
|
Huayuu(HUAYUU) has completed the information registration and certification for ChemicalBook.com
CompanyOctober 11, 2026

Huayuu(HUAYUU) has completed the information registration and certification for ChemicalBook.com

Hangzhou Huayuu Biopharma Co., Ltd.(HUAYUU)has completed the information registration and certification for ChemicalBook.com

CPHI Europe 2026 Milan
IndustrySeptember 26, 2026

CPHI Europe 2026 Milan

CPHI Europe 2026, also known as the European World Pharmaceutical Raw Materials Exhibition, will be held at the Fiera Milano in Milan, Italy, from October 6th to 8th, 2026. Hangzhou Huayuu Biopharma Co., Ltd. (HUAYUU) will participate in this event, paying close attention to the live show and new industry information online in real time, seeking opportunities for development and cooperation.(HUAYUUbio CPHI Milan 2026)

BIO CHINA International Bio-fermentation & Biopharmaceutical Exhibition 2026 (Hangzhou)
IndustrySeptember 6, 2026

BIO CHINA International Bio-fermentation & Biopharmaceutical Exhibition 2026 (Hangzhou)

Hangzhou Huayuu Biopharmaceutical Co., Ltd.(HUAYUU) will attend the 2026 BIO CHINA International Bio-fermentation Exhibition in Hangzhou to stay abreast of industry trends and news, and to participate in exchange forums.

Brand identity update of Huayuu Biomedicine
CompanyAugust 13, 2026

Brand identity update of Huayuu Biomedicine

Hangzhou Huayuu Biomedical is a service provider specializing in research and development of bioactive ingredients, focusing on peptides and plant extracts. We provide high-purity raw materials, customized research and development, as well as technical support solutions for the pharmaceutical, health food, and functional cosmetics industries.

Major Breakthrough in Cell Therapy Technology
TechnologyJuly 27, 2026

Major Breakthrough in Cell Therapy Technology

Our R&D team achieved a key technological breakthrough in cell therapy.

Huayuu Biopharma Completes Series B Funding
CompanyJuly 27, 2026

Huayuu Biopharma Completes Series B Funding

The company successfully completed Series B funding .

Huayuu Invited to 2026 Biopharma Industry Forum
IndustryJuly 27, 2026

Huayuu Invited to 2026 Biopharma Industry Forum

Our CEO was invited to speak at the industry forum.

Leave a Message